Immunterapiens rolle i behandlingen af kolorektalcancer

Adile Orhan, Sara Mørup, Laurids Østergaard Poulsen, Per Pfeiffer, Camilla Qvortrup, Ismail Gögenur

Abstract

In Denmark, around 4,500 people are diagnosed with colorectal cancer (CRC) annually. This review investigates that while the efficacy of immunotherapy in CRC is still being studied, immunotherapy is currently only indicated in the treatment of mismatch-repair deficient (dMMR) metastatic CRC, which accounts for 10-15% of patients. Recent studies indicate high rates of pathologic response in dMMR CRC treated with pre-operative immunotherapy while large-scale studies on novel immunotherapy combinations are ongoing.

Bidragets oversatte titelThe role of immunotherapy in the treatment of colorectal cancer
OriginalsprogDansk
ArtikelnummerV06230371
TidsskriftUgeskrift for Laeger
Vol/bind185
Udgave nummer51
ISSN0041-5782
StatusUdgivet - 18 dec. 2023

Emneord

  • Colonic Neoplasms
  • Colorectal Neoplasms/diagnosis
  • Humans
  • Immunotherapy
  • Rectal Neoplasms

Fingeraftryk

Dyk ned i forskningsemnerne om 'Immunterapiens rolle i behandlingen af kolorektalcancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater